SCHEDULE: BlackRock Discloses 4.96% Passive Stake in ORTHOPEDIATRICS CORP
Beneficial Ownership Disclosure
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.96% beneficial ownership stake in ORTHOPEDIATRICS CORP as of June 30, 2025, held for investment purposes.
Summary
- BlackRock, Inc. reported beneficial ownership of 1,230,784 shares of ORTHOPEDIATRICS CORP common stock.
- This ownership represents 4.96% of the total outstanding common stock of ORTHOPEDIATRICS CORP.
- The shares are held in the ordinary course of business and were not acquired for the purpose of changing or influencing control of the issuer.
- BlackRock, Inc. holds sole voting power over 1,196,523 shares and sole dispositive power over 1,230,784 shares, with no shared voting or dispositive power reported.
- The filing is an Amendment No. 1 to a Schedule 13G, filed under Rule 13d-1(b).
- BlackRock Investment Management, LLC, a subsidiary of BlackRock, Inc., is noted as beneficially owning 5% or greater of the outstanding shares of ORTHOPEDIATRICS CORP, although the aggregate reported by BlackRock, Inc. for its specified reporting business units is 4.96%.
Sentiment
Score: 5
Explanation: The filing is a neutral, routine disclosure of passive ownership by a large institutional investor. It does not contain positive or negative performance indicators for the issuer.
Positives
- A major institutional investor, BlackRock, Inc., maintains a significant passive stake in ORTHOPEDIATRICS CORP, indicating continued investment interest.
- The holding is stated to be for investment purposes in the ordinary course of business, not for influencing control, which suggests a stable, long-term investment perspective from BlackRock.
Future Outlook
The document does not provide any forward-looking statements or guidance regarding ORTHOPEDIATRICS CORP's future performance or outlook.
Management Comments
- The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
Industry Context
This filing is a routine disclosure of an institutional investor's passive stake and does not provide specific industry context or trends for the medical device or orthopedics sector. It indicates BlackRock's continued investment in ORTHOPEDIATRICS CORP, a company operating in the orthopedics industry.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Grant | BlackRock, Inc. granted a Power of Attorney on January 21, 2025, authorizing specific individuals to execute and file documents related to ownership or control-person reporting requirements with regulatory authorities, including SEC filings. | 2025-01-21 | Streamlines the process for BlackRock to comply with various ownership disclosure regulations by designating authorized signatories. |
Stakeholder Impact
- Shareholders: The disclosure of BlackRock's continued significant, albeit passive, stake may provide some confidence to other investors, as it indicates a major institutional investor's ongoing interest in the company.
Key Dates
| Date | Description |
|---|---|
| 2025-01-21 | Date of the Power of Attorney granted by BlackRock, Inc. to its attorneys-in-fact for SEC filings. |
| 2025-06-30 | Date of the event which required the filing of this Schedule 13G amendment, reflecting BlackRock's beneficial ownership in ORTHOPEDIATRICS CORP. |
| 2025-07-17 | Date the Schedule 13G Amendment No. 1 was signed by BlackRock, Inc. |
Keywords
ORTHOPEDIATRICS CORP, BlackRock Inc., Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Passive Investment, SEC Filing, Medical Devices, Orthopedics
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.